Insulet Corp

PODD: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
k!<LOCK|JkrY&LOCK|>RV%$pSw

Insulet Earnings: Another Stellar Quarter Underscores the Appeal of Omnipod

Similar to previous quarters in 2025, Insulet delivered third-quarter results with revenue growth running up 28% and operating margin improvement of 50 basis points year over year.

Sponsor Center